India is strengthening efforts to eliminate viral hepatitis as a public health threat by 2030 under the National Viral Hepatitis Control Programme (NVHCP).
Hepatitis is an inflammation of the liver mainly caused by viral infections, toxic substances and autoimmune conditions.
The five major hepatitis virus types are Hepatitis A, B, C, D and E, with Hepatitis B and C causing severe chronic liver diseases.
Hepatitis B and C can lead to liver cirrhosis and primary liver cancer if untreated.
The NVHCP provides free screening, diagnosis and antiviral treatment for Hepatitis B and C across India.
The programme supports affordable treatment through generic medicines and expands services from district hospitals to Primary Health Centres (PHCs).
India's hepatitis elimination strategy aligns with United Nations Sustainable Development Goal 3 (SDG 3.3), which aims to end communicable diseases by 2030.